| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Development Officer
1 company
Kaiser Peter is a Chief Development Officer at OCUL. Recent filings cover 0 purchases and 10 sales. Those positions are worth an estimated $1.8M at current prices.
Our model assigns Kaiser Peter a below-average insider score of 38/100, based on 7 past trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -26.5%.
Kaiser Peter's largest disclosed position is in OCUL as Chief Development Officer, worth about $1.8M. The recent filings there lean toward selling, a net 43,353 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 2, 2026 | OCUL Ocular Therapeutix, Inc. | Chief Development Officer | Sell10b5-1 | 9,990 | $7.05 | $70,429.50 | -3.8% | - | - | |
| Aug 24, 2026 | OCUL Ocular Therapeutix, Inc. | Chief Development Officer | Sell10b5-1 | 3,035 | $10.77 | $32,686.95 | -1.1% | - | - | |
| May 26, 2026 | OCUL Ocular Therapeutix, Inc. | Chief Development Officer | Sell10b5-1 | 2,967 | $8.20 | $24,329.40 | -1.1% | +30.0% | - | |
| Feb 23, 2026 | OCUL Ocular Therapeutix, Inc. | Chief Development Officer | Sell10b5-1 | 2,810 | $8.28 | $23,266.80 | -1.0% | -1.5% | - | |
| Nov 24, 2025 | OCUL Ocular Therapeutix, Inc | Chief Development Officer | Sell10b5-1 | 3,007 | $12.02 | $36,144.14 | -1.5% | -30.4% | - | |
| Oct 2, 2025 | OCUL Ocular Therapeutix, Inc | Chief Development Officer | Sell10b5-1 | 9,653 | $11.03 | $106,472.59 | -4.7% | +9.8% | -37.1% | |
| Aug 25, 2025 | OCUL Ocular Therapeutix, Inc | Chief Development Officer | Sell10b5-1 | 3,011 | $12.04 | $36,252.44 | -1.5% | +1.9% | -8.3% | |
| May 23, 2025 | OCUL Ocular Therapeutix, Inc | Chief Development Officer | Sell10b5-1 | 2,974 | $7.17 | $21,323.58 | -1.4% | +66.2% | +12.7% | |
| Feb 24, 2025 | OCUL Ocular Therapeutix, Inc | Chief Development Officer | Sell10b5-1 | 3,009 | $6.87 | $20,671.83 | -1.4% | +3.3% | +33.3% | |
| Nov 25, 2024 | OCUL Ocular Therapeutix, Inc | Chief Development Officer | Sell10b5-1 | 2,897 | $9.01 | $26,101.97 | -1.3% | -26.1% | +33.4% |